Monitor for subsequent Form 4 filings confirming actual sales. The large proposed sale by a major institutional affiliate suggests potential near-term selling pressure. Traders should watch for accelerated execution through Goldman Sachs and consider the overhang on CELC's stock price.
CELC drugs
CELC drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 15 $91.51entry
- T+1 · 4mo ago −3.52%α −2.98% · $88.29
- T+5 · 4mo ago −1.50%α −0.52% · $90.14
- T+20 · 3mo ago +0.62%α −1.72% · $92.08
- T+60 · 6w ago −25.83%α −28.37% · $67.87
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Baker Brothers affiliates (667, L.P. and Baker Brothers Life Sciences L.P.) filed Form 144 notices to sell a combined 3,100,000 shares of Celcuity Inc. common stock, valued at approximately $317.75 million. This represents about 6.35% of outstanding shares and signals a significant reduction in exposure by a major healthcare-focused institutional investor.
Key Facts
- 667, L.P. intends to sell 261,368 shares worth ~$26.79 million.
- Baker Brothers Life Sciences L.P. intends to sell 2,838,632 shares worth ~$290.96 million.
- Combined proposed sale: 3,100,000 shares, approximately $317.75 million (6.35% of outstanding shares).
- Shares were purchased between 12/13/2024 and 5/16/2025 in open market transactions.
- Filing signed by Scott L. Lessing, President of Baker Bros. Advisors LP, the investment adviser to both entities.
Financial Impact
Approximately $317.75 million of stock to be sold, representing ~6.35% of outstanding shares (based on 48,766,288 shares outstanding noted in the filing).
Risk Factors
- Large block sale could depress share price if executed rapidly.
- Signals reduced conviction from a knowledgeable long-term investor (Baker Brothers).
- Remaining 93.65% of shares still held by other insiders/institutions, but this sale is material.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (CELC), Batch item 1 | 0001104659-26-083659 |
| Document: 0001104659-26-083659-index.html | 0001104659-26-083657 |
| Document: 0001104659-26-083659.txt | 0001104659-26-083659 |
| 144 Filing (CELC), Batch item 4 | 0001104659-26-083657 |
| Document: 0001104659-26-083657-index.html | 0001104659-26-083659 |
| Document: 0001104659-26-083657.txt | 0001104659-26-083659 |
| 144 Filing (CELC), Batch item 7 | 0001104659-26-083659 |
| Document: 0001104659-26-083659-index.html | 0001104659-26-083659 |
| Document: 0001104659-26-083659.txt | 0001104659-26-083659 |
| 144 Filing (CELC), Batch item 10 | 0001104659-26-083657 |
| Document: 0001104659-26-083657-index.html | 0001104659-26-083659 |
| Document: 0001104659-26-083657.txt | 0001104659-26-083659 |
Track record
26 reports on CELC
6 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +26.84% at T+20 after the Jun 11, 2026 report. 8 of 12 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $62.58 Now $60.57 −3.21% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $64.37 Now $60.57 −5.90% settles Nov 23
- Nov 9, 20267d ago Press Release Bullish 5/10 Entry $70.37 to $60.57 Now $60.57 −13.93% ▼ −13.93% −12.23% vs SPY
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $66.79 to $64.37 Now $60.57 −9.31% ▼ −3.62% −6.22% vs SPY
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $69.72 to $67.05 Now $60.57 −13.12% ▼ −3.83% −3.24% vs SPY
- Oct 24, 202623d ago Press Release Bullish 6/10 Entry $65.80 to $69.13 Now $60.57 −7.95% ▲ +5.06% +6.32% vs SPY
- Oct 5, 20266w ago 3 Neutral 2/10 Entry $71.25 to $63.19 Now $60.57 −14.99% ▼ −11.31% −11.17% vs SPY
- Oct 2, 20266w ago 8-K Neutral 2/10 Entry $72.10 to $67.94 Now $60.57 −15.99% ▼ −5.77% −6.93% vs SPY
- Sep 30, 20266w ago 8-K Bullish 6/10 Entry $79.52 to $65.78 Now $60.57 −23.83% ▼ −17.28% −19.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers